Pulmonary MALT lymphoma: A case report and review of the literature

Isaacson P and Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 52:1410–1416. 1983. View Article : Google Scholar : PubMed/NCBI

Harris N, Jaffe E, Stein H, et al: A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood. 84:1361–1392. 1994.PubMed/NCBI

Cadranel J, Wislez M and Antoine M: Primary pulmonary lymphoma. Eur Respir J. 20:750–762. 2002. View Article : Google Scholar : PubMed/NCBI

Klein TO, Soll BA, Issel BF, et al: Bronchus-associated lymphoid tissue lymphoma and Mycobacterium Tuberculosis infection: an unusual case and a review of the literature. Respir Care. 52:755–758. 2007.PubMed/NCBI

Borie R, Wislez M, Thabut G, et al: Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J. 34:1408–1416. 2009. View Article : Google Scholar : PubMed/NCBI

Xu HY, Jin T, Li RY, et al: Diagnosis and treatment of pulmonary mucosa-associated lymphoid tissue lymphoma. Chin Med J. 20:648–651. 2007.

Bae YA, Lee KS, Han J, et al: Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients. Chest. 133:433–440. 2008. View Article : Google Scholar

Kurtin PJ, Myers JL, Adlakha H, et al: Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 25:997–1008. 2001. View Article : Google Scholar : PubMed/NCBI

Lazar EB, Whitman GJ and Chew FS: Lymphoma of bronchus-associated lymphoid tissue. AJR Am J Roentgenol. 167:1161996. View Article : Google Scholar : PubMed/NCBI

Boulanger E, Meignin V, Baia M, et al: Mucosa-associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection. Br J Haematol. 140:470–474. 2008. View Article : Google Scholar : PubMed/NCBI

Ahmed S, Kussick SJ, Siddiqui AK, et al: Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer. 40:1320–1326. 2004. View Article : Google Scholar : PubMed/NCBI

Zinzani PL, Pellegrini C, Gandolfi L, et al: Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. Hematol Oncol. 31:183–188. 2013. View Article : Google Scholar

Jäger G, Neumeister P, Quehenberger F, et al: Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of phase II trial. Ann Oncol. 11:1722–1723. 2006. View Article : Google Scholar

Troch M, Streubel B, Petkov V, et al: Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res. 27:3633–3637. 2007.PubMed/NCBI

Ferraro P, Trastek VF, Adlakha H, et al: Primary non-Hodgkin’s lymphoma of the lung. Ann Thorac Surg. 69:933–937. 2000. View Article : Google Scholar

Oh SY, Kim WS, Kim JS, et al: Pulmonary marginal zone B-cell lymphoma of MALT type - what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. Ann Hematol. 89:563–568. 2010. View Article : Google Scholar

Conconi A, Martinelli G, Thiéblemont C, et al: Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 102:2741–2745. 2003. View Article : Google Scholar : PubMed/NCBI